Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3UN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,219
Award facts
- Contract value 100% obligated
- $59,218.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,218.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kesimpta 20 mg/0.4 ml pen auto-injectors, with an ultimate completion date of January 27, 2026. This is a non-set-aside competitive award, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial indefinite delivery contract with DLA Troop Support Medical valued at up to $999.9 million through December 31, 2031, serving as the primary vehicle for pharmaceutical supply to military healthcare systems globally.
Kesimpta is a specialty pharmaceutical product indicated for treating multiple sclerosis, reflecting the breadth of therapeutic areas supported through the DLA's pharmaceutical supply chain to military treatment facilities and veterans' healthcare programs. AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills federal procurement requirements for brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order represents a discrete task order under the larger IDC framework, demonstrating the contractor's ongoing capability to provide critical medical commodities to support Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FG3UN?
SPE2DR26FG3UN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FG3UN worth?
The government has obligated $59,219 on SPE2DR26FG3UN.
Is contract SPE2DR26FG3UN an order under another contract?
Yes. SPE2DR26FG3UN is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3UN competed?
The extent of competition for SPE2DR26FG3UN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award